Microbix has recently developed the COVID-19 Quality Assessment Products (QAPs) products below for External Quality Assessment and Proficiency Testing uses, for various Research Use Only (RUO) uses. Additionally, the products were registered for use as an external quality control for IVD use in multiple jurisdictions (FDA, CE, TGA and HC).
As for all Microbix QAPs™, this COVID-19 product is a whole-genome workflow support tool that includes 100% of the genetic sequences of the virus and emulates real patient samples while being consistent, non-infectious, and stable. As such, it contains all possible NAT viral targets – ensuring compatibility across all current and future NATs. This broad compatibility and guaranteed utility is particularly relevant for External Quality Assurance Programs that assess and ensure the performance of testing labs.